2008
DOI: 10.1001/archneurol.2007.17
|View full text |Cite
|
Sign up to set email alerts
|

Neuromyelitis Optica and Non–Organ-Specific Autoimmunity

Abstract: Background: Neuromyelitis optica (NMO) is often associated with other clinical or serological markers of non-organ-specific autoimmunity. Objective: ToevaluatetherelationshipbetweenNMOspectrum disorders (NMOSDs), including NMO, longitudinally extensive transverse myelitis, and recurrent optic neuritis, and autoimmune disease. We concentrated on the association with systemic lupus erythematosus (SLE), Sjögren syndrome (SS), or serological evidence of these disorders, which commonly is a source of diagnostic con… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1
1

Citation Types

28
390
5
17

Year Published

2008
2008
2016
2016

Publication Types

Select...
9

Relationship

1
8

Authors

Journals

citations
Cited by 526 publications
(440 citation statements)
references
References 22 publications
28
390
5
17
Order By: Relevance
“…12,19,20 Whereas the AQP4-ab detection is a specific marker that distinguishes neuromyelitis optica (NMO) from other etiologies, in these patients, coexisting pathologies is postulated. 19 In two of our patients have been tested for the presence of these antibodies by IFI with negative results. The sensitivity depends on the method of detection: assay based on cells transfected with AQP4-M23 isoform were the most sensitive but is not widely available.…”
Section: Resultsmentioning
confidence: 99%
“…12,19,20 Whereas the AQP4-ab detection is a specific marker that distinguishes neuromyelitis optica (NMO) from other etiologies, in these patients, coexisting pathologies is postulated. 19 In two of our patients have been tested for the presence of these antibodies by IFI with negative results. The sensitivity depends on the method of detection: assay based on cells transfected with AQP4-M23 isoform were the most sensitive but is not widely available.…”
Section: Resultsmentioning
confidence: 99%
“…Approximately 3% of patients with NMO have coexisting SLE or SjS, and CNS-SjS patients with optic nerve neuritis or longitudinal myelitis (conditions called "NMO spectrum disorder") often present positive for AQP4-Ab [4,6,7]. To our knowledge, this is the first reported assessment of tacrolimus in patients with CNS-SjS with AQP4-Ab.…”
mentioning
confidence: 84%
“…Inflammatory myelitis can be further divided depending on whether gray or white matter is primarily involved [30]. High disease activity is associated with gray matter dysfunction and overt inflammation, whereas antiphospholipid and NMO-IgG/ antiaquaporin 4 antibodies, along with lower disease activity, correlate with white matter dysfunction [30,31]. Optic neuritis can occur without myelitis and it is either inflammatory or ischemic (associated with antiphospholipid antibody positivity) [5].…”
Section: Sle Myelopathymentioning
confidence: 99%
“…Transverse myelitis has also been described in patients with pSS [3,82,83], and in a small percentage it may be accompanied by brain MS-like lesions or by optic neuritis making, at times, the distinction from a primary demyelinating disease such as MS or NMO rather difficult [31,80]. The meninges can also be affected, alone or in the context of meningoencephalitis [84], while in some cases a subacute encephalopathy presenting with memory loss, cognitive dysfunction, visual disturbances, and reduced concentration and attention has been noted [80].…”
Section: Sjögren's Syndromementioning
confidence: 99%